LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration
Burton B, Parodi MB, Jürgens I, Zanlonghi X, Hornan D, Roider J, Lorenz K, Munk MR, Croissant CL, Tedford SE, Walker M, Ruckert R, Tedford CE. · Ophthalmology and therapy · 2023 · Randomized sham-controlled multicentre trial
Original publication · Original publication
Recorded summary
The trial assessed repeated multiwavelength photobiomodulation in non-exudative macular degeneration and reported visual-acuity and anatomical outcomes.
Recorded limitations
This clinical trial did not measure target-gene expression. The reported complete-treatment analyses and eye-level outcomes need to be interpreted within the trial design.
Evidence and provenance
Chapter Trust Factor uses a minimum of three distinct qualifying studies. Publication records retain their own evidence and assessment.
Study design and assessment
- design
- Randomized sham-controlled multicentre trial
- assessment
- Not recorded
- trust Factor
- score
- 2
- scope
- Paper
- status
- assessed
- randomized Controlled Trial
- true
- blinding
- not-confirmed
- peer Reviewed
- true
- basis
- Randomized controlled design recorded in the publication-specific design or bibliographic indexing.
- sources
https://pubmed.ncbi.nlm.nih.gov/36588113/ · https://doi.org/10.1007/s40123-022-00640-6
- review Scope
- Existing publication-specific assessments and bibliographic indexing; no blanket full-text appraisal.
- assessed At
- 2026-10-27
- jadad
- status
- unassessed
- score
- Not recorded
- evidence
- Not recorded
Topics and recorded topic scores
None recordedCitation snapshot and identifiers
- id
- pmid-36588113
- doi
- 10.1007/s40123-022-00640-6
- pmid
- 36588113
- citation Snapshot
- Not recorded
- citations By Collection
- vision
- Not recorded
Complete approved library record
- id
- pmid-36588113
- publication Key
- Not recorded
- aliases
- None recorded
- title
- LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration
- journal
- Ophthalmology and therapy
- neurotransmitters
- None recorded
- year
- 2023
- authors
- Burton B, Parodi MB, Jürgens I, Zanlonghi X, Hornan D, Roider J, Lorenz K, Munk MR, Croissant CL, Tedford SE, Walker M, Ruckert R, Tedford CE.
- design
- Randomized sham-controlled multicentre trial
- kind
- Journal article
- identity Conflict
- Not recorded
- doi
- 10.1007/s40123-022-00640-6
- pmid
- 36588113
- urls
https://doi.org/10.1007/s40123-022-00640-6 · https://pubmed.ncbi.nlm.nih.gov/36588113/
- collections
vision
- categories
Clinical & self-report
- targets
- None recorded
- priority
- 1
- quotes
- None recorded
- summary
- The trial assessed repeated multiwavelength photobiomodulation in non-exudative macular degeneration and reported visual-acuity and anatomical outcomes.
- limitation
- This clinical trial did not measure target-gene expression. The reported complete-treatment analyses and eye-level outcomes need to be interpreted within the trial design.
- citation Count
- Not recorded
- paper Trust Assessment
- score
- 2
- scope
- Paper
- status
- assessed
- randomized Controlled Trial
- true
- blinding
- not-confirmed
- peer Reviewed
- true
- basis
- Randomized controlled design recorded in the publication-specific design or bibliographic indexing.
- sources
https://pubmed.ncbi.nlm.nih.gov/36588113/ · https://doi.org/10.1007/s40123-022-00640-6
- review Scope
- Existing publication-specific assessments and bibliographic indexing; no blanket full-text appraisal.
- assessed At
- 2026-10-27
- citations By Collection
- vision
- Not recorded
- topics
- None recorded
- journal Key
- ophthalmologyandtherapy
- journal Label
- Ophthalmology and therapy
- chapter Entries
- None recorded
- jadad
- status
- unassessed
- score
- Not recorded
- condition Evidence
- None recorded
- conditions
- None recorded
- topic Trust Scores
- None recorded
- full Text
- status
- not-indexed
- retrieval Available
- false